rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
1999-7-14
|
pubmed:abstractText |
The cardioprotective effects of the adenosine A3 receptor in a cardioplegia model have not been described. We tested the hypothesis that infusion of the A3 receptor agonist, Cl-IB-MECA (100 nM), as a pretreatment (PTx) and/or as a cardioplegic (CP) additive reduces postischemic myocardial injury.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0003-4975
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1732-7
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:10391283-Adenosine,
pubmed-meshheading:10391283-Animals,
pubmed-meshheading:10391283-Creatine Kinase,
pubmed-meshheading:10391283-Evaluation Studies as Topic,
pubmed-meshheading:10391283-Heart Arrest, Induced,
pubmed-meshheading:10391283-Ischemic Preconditioning, Myocardial,
pubmed-meshheading:10391283-Myocardial Reperfusion Injury,
pubmed-meshheading:10391283-Purinergic P1 Receptor Agonists,
pubmed-meshheading:10391283-Random Allocation,
pubmed-meshheading:10391283-Rats,
pubmed-meshheading:10391283-Rats, Sprague-Dawley,
pubmed-meshheading:10391283-Ventricular Function, Left
|
pubmed:year |
1999
|
pubmed:articleTitle |
Adenosine A3 pretreatment before cardioplegic arrest attenuates postischemic cardiac dysfunction.
|
pubmed:affiliation |
Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|